After a perfect touch of the .618 Fib retracement level, now NRXP is ready to aim higher! Get ready for action! My first price target is 35usd. Today NRx was granted Fast Track Designation by the U.S. Food and Drug Administration for ZYESAMI (aviptadil) for the treatment of Critical COVID-19 with respiratory failure! NRx Pharmaceuticals has also a Partnership...
Tomorrow Chembio Diagnostics CEMI will Report Second Quarter 2021 Financial Results. Things to consider: $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil $4 million purchase order from the Partnership for Supply Chain Management (PFSCM), for the purchase of HIV 1/2 STAT-PAK Assay for shipment to Ethiopia those are just some...
WORX stock tested a key FIb level on Wednesday being the 50 fib line after plotting the top anchor at the recent high the first time WORX busted above the 50 fib. Before this latest round of testing, the last time WORX reached this key level it was rejected heavily. A few weeks ago, the company announced that it had regained compliance with the NASDAQ listing...
While I totally missed this spike formation months ago, it is already happening, and the charts are telling us it is already a spike wave. Today, China says it will mass test all 11 million of the Wuhan residents, and it has locked down a number of cities in swift response. the next couple of weeks should see China spike, followed by USA spike, and they may start...
Time for an update... Singapore is not enjoying it, but it is in a surprise wave. IT should start to taper off, but the tail would be long... Indonesia was as projected, and appears to be slowing slightly. Malaysia is the surprise, as instead of tailing off, a new spike over the last three weeks emerged and the trajectory indicates higher levels over the next...
AHPI continues testing this 382 fib level and with more delta variant to go around, related stocks are gaining some nice sympathy momentum. But is it enough to get it up and over the "hump" so to speak. This same 382 level was a higher traffic area of support last July and August with upper resistance being around the 236 fib level. Something interesting to look...
Last week, in an interview on CNBC, legendary trader and investor Stanley Druckenmiller sounded an alarm. He told reporters on the financial news network, “I can’t find any period in history where monetary and fiscal policy were this out of step with the economic circumstances, not one…I will be surprised if we’re not out of the stock market by the end of the...
The headline: vaccinated people are getting and spreading Delta This afternoon the CDC announced that a Delta variant outbreak in Massachusetts infected a lot of vaccinated people. The vaccines provided protection against death and hospitalization, but less-than-expected protection against infection and transmission. The disturbing data helps me make sense of...
After good fundamental news for ICX token, and technical position is matched for a jump level and then pullback to run... see the chart's lines and marked price... AqayeSalehi
Had to go way back to find some levels to plot against and 2017 looks like it's the mark. The interesting part is that this 236 area has been an area of traffic in the past. Considering that PAVM failed to break and hold (for now) once again might reinforce that idea. Prior to reaching those highs, the stock tested this area a few more times but failed at every...
On 6/11/2021 Piper Sandler brokerage Initiated Coverage giving a price target of $18.00 VXRT Vaxart today announced that it has shown for the first time in clinical trials that its oral tablet vaccine platform successfully boosted immune responses in subjects previously vaccinated with a Vaxart oral vaccine more than a year earlier. (prnewswire.com) This is in...
Was just speaking to a good buddy who saw an interview where someone said that in a few weeks, the Delta wave would be over. I pulled out the chart, and by any measure, it does not appear so! The only time this model failed was the Singapore KTV Club surge, which is an anomaly, and a gamechanger... much as an awakening call. Otherwise, it has been pretty darn...
Dyadic International signed a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. The Rubic Consortium is made up of promoters of the project representing public health, medical, academia, vaccine technology, technology transfer and economics sectors. Arrangement includes C1 COVID-19 vaccine technology transfer and licensing...
AUDUSD refreshes intraday low under 0.7400 threshold as covid woes escalate in Australia, taking down the overall risk sentiment amid pre-Fed cautious mood. The same reverse the Aussie pair’s breakout of a three-week-old resistance line, portrayed the previous day, by staying below a broad horizontal resistance area since July 09. Hence, the quote is likely to...
Trade Analysis based on Price Action. With risk management you will never loss Kind regards; ridethemacro
After strong Q1 and Q2 earnings. With fears of delta covid variant. It seems that Zoom stock is about start a bull cycle. Beside the strong fundamentals and supportive circumstances. This convintion is also build upon chart technicals where the price has broke through a falling channel, and now testing the upper trend + 50 day moving average. As shown the candle...
Trade idea based on Fundamentals & price Action With risk management you will never loss.. Kind regards; Ridethemacro
Biotech sector is getting hot, especially for companies connected to COVID-19 vaccine and treatments development... BIOV chart looks rip for a breakout with MACD closing in on bullish cross and a major catalyst in the form of FDA approval of its Phase I/II study: FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical...